{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:30:42Z","timestamp":1761006642415,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1016\/s1053-8119(03)00166-6","type":"journal-article","created":{"date-parts":[[2003,6,9]],"date-time":"2003-06-09T16:43:51Z","timestamp":1055177031000},"page":"1205-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings"],"prefix":"10.1016","volume":"19","author":[{"given":"Kjell","family":"Erlandsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo A.","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Ell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent J.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn S.","family":"Pilowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1053-8119(03)00166-6_BIB1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002590050028","article-title":"Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography","volume":"27","author":"Bergstr\u00f6m","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1192\/bjp.175.3.231","article-title":"In vivo occupancy of striatal and temporal cortical D2\/D3 dopamine receptors by typical antipsychotic drugs\u2014a [123I] epidepride single photon emission tomography (SPET) study","volume":"175","author":"Bigliani","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002130000435","article-title":"Striatal and temporal cortical D2\/D3 receptor occupancy by olanzapine\u2014a 123I epidepride single photon emission tomography (SPET) study","volume":"150","author":"Bigliani","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004714-200302000-00002","article-title":"Optimising limbic selective D2\/D3 receptor occupancy by risperidone\u2014a [123I]-epidepride SPET study","volume":"23","author":"Bressan","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/jcbfm.1993.6","article-title":"Comparison of bolus and infusion methods for receptor quantitation","volume":"13","author":"Carson","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1109\/TNS.1978.4329385","article-title":"A method for attenuation correction in radionuclide computed tomography","volume":"25","author":"Chang","year":"1978","journal-title":"IEEE Trans. Nucl. Sci."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/jcbfm.1989.98","article-title":"Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET\u2014a comparison to the equilibrium analysis","volume":"9","author":"Farde","year":"1989","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 receptor occupancy in patients treated with classical neuroleptics and clozapine","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s002130050420","article-title":"A PET study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients","volume":"133","author":"Farde","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1098-2396(19991215)34:4<290::AID-SYN5>3.0.CO;2-B","article-title":"Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors","volume":"34","author":"Fujita","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0022-3565(25)11150-6","article-title":"Extrastriatal dopamine D2 receptors","volume":"261","author":"Janowsky","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"1988","series-title":"Principles of Computerized Tomographic Imaging","author":"Kak","key":"10.1016\/S1053-8119(03)00166-6_BIB13"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1176\/appi.ajp.159.6.1064-a","article-title":"Regional selectivity in clozapine treatment?","volume":"159","author":"Kessler","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/jcbfm.1991.130","article-title":"Compartmental analysis of [11C]Flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography","volume":"11","author":"Koeppe","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","article-title":"Comparison of methods for analysis of clinical [11C]Raclopride studies","volume":"16","author":"Lammertsma","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"NeuroImage"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB18","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1109\/83.465107","article-title":"Globally convergent algorithms for maximum a posteriori transmission tomography","volume":"4","author":"Lange","year":"1995","journal-title":"IEEE Trans. Im. Process."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB19","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1073\/pnas.91.10.4353","article-title":"A common action of clozapine, haloperidol and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex","volume":"91","author":"Lidow","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB20","doi-asserted-by":"crossref","first-page":"13591","DOI":"10.1073\/pnas.96.24.13591","article-title":"Cognition, schizophrenia, and the atypical antipsychotic drugs","volume":"96","author":"Meltzer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1109\/42.97591","article-title":"A practical method for position-dependent Compton-scatter correction in single emission CT","volume":"10","author":"Ogawa","year":"1991","journal-title":"IEEE Trans. Med. Im."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1006\/nimg.2001.0879","article-title":"Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy\u2014a simulation study based on experimental data","volume":"14","author":"Olsson","year":"2001","journal-title":"NeuroImage"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00004647-199910000-00013","article-title":"Quantification of [11C]FLB 457 Binding to extrastriatal dopamine receptors in human brain","volume":"19","author":"Olsson","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB25","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic and histaminergic receptors to clinical potency","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(92)90467-H","article-title":"Clozapine, single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia","volume":"340","author":"Pilowsky","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(05)63079-6","article-title":"Limbic selectivity of clozapine","volume":"350","author":"Pilowsky","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1192\/bjp.177.5.408","article-title":"The action of quetiapine at striatal and extra-striatal D2\/D3 receptors in vivo","volume":"177","author":"Stephenson","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0031-6997(24)01483-2","article-title":"Antipsychotic drugs","volume":"53","author":"Strange","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1461145799001431","article-title":"Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET","volume":"2","author":"Suhara","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/S1053-8119(03)00166-6_BIB31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archpsyc.59.1.25","article-title":"Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia","volume":"59","author":"Suhara","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1176\/appi.ajp.158.6.926","article-title":"No support for regional selectivity in clozapine-treated patients","volume":"158","author":"Talvik","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/syn.890150303","article-title":"Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide","volume":"15","author":"Votaw","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/S1053-8119(03)00166-6_BIB34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.179.6.503","article-title":"Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia","volume":"179","author":"Xiberas","year":"2001","journal-title":"Br. J. Psychiatry"}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811903001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811903001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:38:55Z","timestamp":1760953135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811903001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S1053811903001666"],"URL":"https:\/\/doi.org\/10.1016\/s1053-8119(03)00166-6","relation":{},"ISSN":["1053-8119"],"issn-type":[{"type":"print","value":"1053-8119"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings","name":"articletitle","label":"Article Title"},{"value":"NeuroImage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1053-8119(03)00166-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Science (USA). All rights reserved.","name":"copyright","label":"Copyright"}]}}